Cite
Orlicka-Płocka M, Fedoruk-Wyszomirska A, Gurda-Woźna D, et al. Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants (Basel). 2021;10(6)doi: 10.3390/antiox10060950.
Orlicka-Płocka, M., Fedoruk-Wyszomirska, A., Gurda-Woźna, D., Pawelczak, P., Krawczyk, P., Giel-Pietraszuk, M., Framski, G., Ostrowski, T., & Wyszko, E. (2021). Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants (Basel, Switzerland), 10(6), . https://doi.org/10.3390/antiox10060950
Orlicka-Płocka, Marta, et al. "Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives." Antioxidants (Basel, Switzerland) vol. 10,6 (2021). doi: https://doi.org/10.3390/antiox10060950
Orlicka-Płocka M, Fedoruk-Wyszomirska A, Gurda-Woźna D, Pawelczak P, Krawczyk P, Giel-Pietraszuk M, Framski G, Ostrowski T, Wyszko E. Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants (Basel). 2021 Jun 12;10(6). doi: 10.3390/antiox10060950. PMID: 34204594; PMCID: PMC8231124.
Copy
Download .nbib